DXCM logo Dexcom : DXCM

DXCM

Stock Data

$84.75

Change up

$1.73 (2.08%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Dexcom Inc specializes in advanced medical devices for diabetes management, offering continuous glucose monitoring (CGM) systems. Their innovative products, including the Dexcom G6 and G7, help both individuals with diabetes and healthcare providers by providing real-time glucose data. Dexcom's technology also supports remote monitoring and integrates with digital health apps, aiming to make diabetes management more effective and less invasive. Based in San Diego, California, Dexcom is a leader in diabetes care technology, continuously working on new solutions like Dexcom Stelo for type 2 diabetes.

Latest Activity

DXCMDexcom
Q2 2026
EPS
$0.70
est $0.61+15.1%
Revenue
$1.31B
est $1.29B+1.4%

Dexcom crushed earnings with a 15% EPS beat and raised full-year guidance as positive results from its CONNECT trial opened a massive new market: type 2 diabetes patients not using insulin. The breakthrough signals CGM adoption is accelerating well beyond its traditional insulin-dependent base, with U.S. revenue up 11% and international revenue surging 19%.

Quarterly EPS — reported vs estimate

All Dexcom Articles

24 Articles

1 2